Evidence map›Paper›PMID 30718141›Full record

ArticleNutrition, metabolism, and cardiovascular diseases : NMCD2019

Circulating n-3 fatty acids and linoleic acid as indicators of dietary fatty acid intake in post-myocardial infarction patients.

K Pertiwi, D E Kok, A J Wanders, J de Goede, P L Zock, J M Geleijnse

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrition, metabolism, and cardiovascular diseases : NMCD, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

K PertiwiDivision of Human Nutrition and Health, Wageningen University, the Netherlands. Electronic address: kamalita.pertiwi@wur.nl.
D E KokDivision of Human Nutrition and Health, Wageningen University, the Netherlands.
A J WandersUnilever R&D, Vlaardingen, the Netherlands.
J de GoedeDivision of Human Nutrition and Health, Wageningen University, the Netherlands.
P L ZockUnilever R&D, Vlaardingen, the Netherlands.
J M GeleijnseDivision of Human Nutrition and Health, Wageningen University, the Netherlands.
Wageningen University & Research · NLUnilever (Netherlands) · NL

Funding

Alpha Omega TrialR01HL076200 · NHLBI · WAGENINGEN UNIVERSITY · PI KROMHOUT, DAAN · 2005 to 2008
$1.9M
NHLBI NIH HHS R01 HL076200
6 · The paper itself

Abstract

BACKGROUND AND

aimsPopulation-based studies often use plasma fatty acids (FAs) as objective indicators of FA intake, especially for n-3 FA and linoleic acid (LA). The relation between dietary and circulating FA in cardiometabolic patients is largely unknown. We examined whether dietary n-3 FA and LA were reflected in plasma lipid pools in post-myocardial infarction (MI) patients. METHODS AND

resultsPatients in Alpha Omega Cohort filled out a 203-item food-frequency questionnaire from which eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha-linolenic acid (ALA), and LA intake were calculated. Circulating individual FA (% total FA) were assessed in cholesteryl esters (CE; n = 4066), phospholipids (PL; n = 838), and additionally in total plasma for DHA and LA (n = 739). Spearman correlation coefficients (r

conclusionsIn post-MI patients, dietary EPA and DHA were well reflected in circulating levels. This was not the case for LA, which may partly be influenced by alcohol use and statins.

Indexed as

Feeding BehaviorAgedAged, 80 and overAlcohol DrinkingBiomarkersCross-Sectional StudiesDiet RecordsDocosahexaenoic AcidsEicosapentaenoic AcidFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLinoleic AcidMaleMiddle AgedMyocardial InfarctionBiomarkersDocosahexaenoic AcidsEicosapentaenoic AcidHydroxymethylglutaryl-CoA Reductase InhibitorsLinoleic AcidBiomarkersCardiac patientsCirculating fatty acidsDietary fatty acidsFood frequency questionnaireLinoleic acidn-3 fatty acidsPlasma fatty acids

Identifiers

PMID30718141
PMCPMC6431560
OpenAlexW2910723186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.